SodaBot fully launched, AI takes over trading, ushering in a new era of intelligent Meme trading
According to ChainCatcher, SodaBot has officially launched. This is an on-chain data-driven DeFi AI intelligent operating system that integrates artificial intelligence (AI), machine learning (ML), and blockchain data, aiming to provide users with real-time and accurate trading signals as well as automated trading strategies. For example, the recent popular “某交易所人生” (a certain exchange life) was also captured and pushed to users by SodaBot at the first moment.
According to the introduction, SodaBot is committed to bridging the information gap between ordinary traders and market insiders, helping users gain a competitive edge in the rapidly changing market through an intelligent decision-making system.
SodaBot features two core Agent modules: Signal Agent and AI Trading Agent. The Signal Agent analyzes on-chain top wallet behaviors through AI, identifying high-probability trading opportunities with a success rate of over 80%. The AI Trading Agent utilizes the RFM model and large language models (LLMs) to track Smart Money and whale movements, automatically executing strategies to achieve high-speed and stable trading around the clock.
The launch of SodaBot marks a new stage for meme trading, moving from “manual gaming” to “AI intelligent execution.”
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
Market Is Primed for a ‘Face Ripper' Rally Thanks to Four Ingredients Says Tom Lee
